-
公开(公告)号:EP3331506B1
公开(公告)日:2019-03-20
申请号:EP16770468.3
申请日:2016-09-16
IPC分类号: A61K9/26 , A61K9/50 , A61K9/48 , A61K31/575 , A61P1/16
-
公开(公告)号:EP4132532A1
公开(公告)日:2023-02-15
申请号:EP21716217.1
申请日:2021-04-07
申请人: Laboratoires C.T.R.S. , Institut National de la Santé et de la Recherche Médicale (INSERM) , Assistance Publique-Hôpitaux de Paris (APHP) , Fondation Imagine , Université Paris Cité , Université Paris-Saclay
-
公开(公告)号:EP3331506A1
公开(公告)日:2018-06-13
申请号:EP16770468.3
申请日:2016-09-16
IPC分类号: A61K9/26 , A61K9/50 , A61K31/575
CPC分类号: A61K9/5026 , A61K9/2081 , A61K9/4866 , A61K9/5089 , A61K31/575 , A61P1/16
摘要: The present invention relates to pediatric drug formulation. Especially, this invention relates to the manufacturing of granules comprising a core comprising a drug having an unpleasant taste, which may be a primary bile acid, such as for example cholic acid, and a taste-masking coating. The purpose of the invention is to fully mask unpleasant taste of the drug, while ensuring its availability at the duodenum biological site.
-
-